AI in precision medicine: From predictive insight to operational confidence in complex clinical trials

Precision medicine is transforming clinical development—but it also introduces greater operational complexity. Finding the right patients, activating the right sites and coordinating diagnostics, laboratories and study teams requires an increasingly connected view of clinical and operational data.

Artificial intelligence (AI) helps turn that data into forward-looking operational insights that enable teams to anticipate challenges, continuously refine forecasts and intervene before issues impact study timelines.

In this white paper, experts from the PPD™ clinical research business of Thermo Fisher Scientific explore a measured approach to AI adoption and the foundations needed to translate AI capabilities into meaningful clinical trial outcomes.

Explore how AI in precision medicine can:

• Shift trial operations from reactive oversight to proactive decision-making
• Identify emerging risks across site activation and patient enrollment
• Turn connected data into more actionable operational intelligence
• Augment clinical expertise while maintaining human accountability
• Improve delivery predictability, speed, quality and consistency